Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2029 (Includes COVID-19 Business Impact)

  • TBI98840
  • August 25, 2020
  • Global
  • 132 pages
  • ROIF Expert
                                          

We have updated Influenza Vaccine Market with respect to COVID-19 Business Impact. Inquire before buying This report focuses on the Influenza Vaccine market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Influenza Vaccine market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.

Global Influenza Vaccine Market: Segment Analysis

The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.

Global Influenza Vaccine Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.

Global Influenza Vaccine Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.

List of Companies Profiled

Sanofi to Dominate the Market Owing to Strong Product Portfolio The influenza vaccine market report says that this market is dominated by Sanofi, a global leader in the healthcare industry. Sanofi has a full-fledged vaccine portfolio, including quadrivalent as well as trivalent vaccines. The company focuses on delivering effective influenza vaccines by constantly upgrading its technologies used in manufacturing influenza vaccines. Other companies like CSL Limited, GlaxoSmithKline plc, AstraZeneca, among others, also have their effective products marketed globally. Additionally, focused R&D, aligned with increasing pipeline candidates to help minimize the serious effects of influenza, is a vital challenge accepted by the market players.

LIST OF KEY COMPANIES PROFILED:

  • Sanofi
  • CSL Limited
  • GlaxoSmithKline plc.
  • AstraZeneca
  • BioDiem
  • Emergent BioSolutions Inc.
  • F. Hoffmann-La Roche Ltd
  • Sinovac Biotech Ltd
  • Other Prominent Players

REPORT COVERAGE

An Infographic Representation of Influenza Vaccine Market View Full Infographic To get information on various segments, share your queries with us Increased awareness about the impact of vaccination on human health and focus on the launch of effective vaccines based on advanced technologies are expected to increase the global influenza vaccine market growth. Along with this, the report provides detailed information regarding various insights into the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the influenza vaccines market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2019 to 2026 to provide the financial competency of the market.

Report Scope & Segmentation

Segmentation

By Type

  • Inactivated
  • Live Attenuated

By Valency

  • Quadrivalent
  • Trivalent

By Age Group

  • Pediatric
  • Adults

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

INDUSTRY DEVELOPMENT:

November 2019

: USFDA approved Sanofis FLUZONE high-dose quadrivalent vaccine for the age group of 65 years and older.

October 2019

: National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institute of Health (NIH), has planned to launch influenza vaccine research centers to fight against influenza on a global scale effectively.

January 2019

: Seqirus received European Commission marketing approval for its seasonal influenza vaccine FLUCELVAX TETRA. Flucelvax was the first cell-based quadrivalent vaccine to be marketed in Europe.

February 2017

: Zydus Cadila launched VAXIFLU in India. Vaxiflu was the first quadrivalent inactivated influenza vaccine to be launched in the country.  

Table of Content
Chapter 1. Methodology and Scope 
1.1. Research Methodology 
1.2. Research Scope & Assumptions 
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Influenza Vaccine Market
3.1. Market Segmentation 
3.2. Market Size and Growth Prospects, 2019 - 2029 
3.3. Value Chain Analysis 
3.4. Market Dynamics 
3.4.1. Market driver analysis 
3.4.2. Market restraint analysis
Chapter 4. Market Size by Application
4.1 Influenza Vaccine Market Consumption by Application (2015-2020) 
4.2 Influenza Vaccine Market Consumption by Application (2020-2029) 

|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form